Triptolide Induces Apoptosis of Gastric Cancer Cells Via Inhibiting the Overexpression of MDM2

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2014 Oct 5

PMID 25280518

Citations 21

Authors

Bo-Yong Wang

Jun Cao

Ji-Wei Chen

Quan-Yan Liu

Affiliations

Soon will be listed here.

Abstract

Triptolide has been reported to exhibit antitumor effects in several cancers. This study investigates the mechanism by which triptolide induces apoptosis of gastric cancer cells. Gastric biopsies were collected for histological evaluation and detection of murine double minute 2 (MDM2) expression. Gastric cancer cells were cultured and treated with different concentrations of triptolide at indicated time points. The expression of MDM2, p53 protein, and target proteins including p21, PUMA, and X-linked inhibitor of apoptosis protein (XIAP) was detected. Apoptosis of cells treated with or without triptolide was evaluated. Our results showed that MDM2 protein was overexpressed in gastric cancer (p < 0.01, resp.). Triptolide induced significant apoptosis of gastric cancer cells in a dose- and time-dependent manner (p < 0.05). In addition, treatment with triptolide strongly inhibited the overexpression of MDM2 in gastric cancer cells, and this MDM2 inhibition led to increased levels of p53 protein and inhibition of XIAP (p < 0.05). However, triptolide failed to increase the expression of p53 target protein p21 and PUMA (p > 0.05). In conclusion, triptolide may induce apoptosis of gastric cancer cells via the inhibition of MDM2 overexpression in a p53-independent manner.

Citing Articles

Triptolide suppresses IL-1β-induced expression of interleukin-8 by inhibiting ROS-Mediated ERK, AP-1, and NF-κB molecules in human gastric cancer AGS cells.

Li S, Sah D, Arjunan A, Ameer M, Lee B, Jung Y Front Oncol. 2025; 14:1498213.

PMID: 39950099 PMC: 11821500. DOI: 10.3389/fonc.2024.1498213.

Triptonide Inhibits the Cervical Cancer Cell Growth via Downregulating the RTKs and Inactivating the Akt-mTOR Pathway.

Zhou L, Peng S, Chen X, Zhu X, Jin A, Liu Y Oxid Med Cell Longev. 2024; 2022:8550817.

PMID: 39282148 PMC: 11401660. DOI: 10.1155/2022/8550817.

Triptolide-induced cuproptosis is a novel antitumor strategy for the treatment of cervical cancer.

Xiao Y, Yin J, Liu P, Zhang X, Lin Y, Guo J Cell Mol Biol Lett. 2024; 29(1):113.

PMID: 39198750 PMC: 11360305. DOI: 10.1186/s11658-024-00623-4.

Ubiquitin-modifying enzymes in thyroid cancer：Mechanisms and functions.

Xiong X, Huang B, Gan Z, Liu W, Xie Y, Zhong J Heliyon. 2024; 10(13):e34032.

PMID: 39091932 PMC: 11292542. DOI: 10.1016/j.heliyon.2024.e34032.

Antitumor mechanisms and future clinical applications of the natural product triptolide.

Bao S, Yi M, Xiang B, Chen P Cancer Cell Int. 2024; 24(1):150.

PMID: 38678240 PMC: 11055311. DOI: 10.1186/s12935-024-03336-y.

References

Asombang A, Rahman R, Ibdah J . Gastric cancer in Africa: current management and outcomes. World J Gastroenterol. 2014; 20(14):3875-9. PMC: 3983443. DOI: 10.3748/wjg.v20.i14.3875. View

Bollschweiler E, Berlth F, Baltin C, Monig S, Holscher A . Treatment of early gastric cancer in the Western World. World J Gastroenterol. 2014; 20(19):5672-8. PMC: 4024776. DOI: 10.3748/wjg.v20.i19.5672. View

Kitzen J, de Jonge M, Lamers C, Eskens F, van der Biessen D, van Doorn L . Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours. Eur J Cancer. 2009; 45(10):1764-72. DOI: 10.1016/j.ejca.2009.01.026. View

Huang M, Zhang H, Liu T, Tian D, Gu L, Zhou M . Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway. Mol Cancer Ther. 2012; 12(2):184-94. PMC: 3570632. DOI: 10.1158/1535-7163.MCT-12-0425. View

Proserpio I, Rausei S, Barzaghi S, Frattini F, Galli F, Iovino D . Multimodal treatment of gastric cancer. World J Gastrointest Surg. 2014; 6(4):55-8. PMC: 4013710. DOI: 10.4240/wjgs.v6.i4.55. View

Shangary S, Wang S . Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy. Annu Rev Pharmacol Toxicol. 2008; 49:223-41. PMC: 2676449. DOI: 10.1146/annurev.pharmtox.48.113006.094723. View

Camargo M, Anderson W, King J, Correa P, Thomas C, Rosenberg P . Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut. 2011; 60(12):1644-9. PMC: 3202077. DOI: 10.1136/gut.2010.236737. View

Vazquez A, Bond E, Levine A, Bond G . The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov. 2008; 7(12):979-87. DOI: 10.1038/nrd2656. View

Chen G, Sordillo E, Ramey W, Reidy J, Holt P, Krajewski S . Apoptosis in gastric epithelial cells is induced by Helicobacter pylori and accompanied by increased expression of BAK. Biochem Biophys Res Commun. 1997; 239(2):626-32. DOI: 10.1006/bbrc.1997.7485. View

10.

Phillips P, Dudeja V, McCarroll J, Borja-Cacho D, Dawra R, Grizzle W . Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Cancer Res. 2007; 67(19):9407-16. DOI: 10.1158/0008-5472.CAN-07-1077. View

11.

Wang W, Yang S, Su Y, Xiao Z, Wang C, Li X . Enhanced antitumor effect of combined triptolide and ionizing radiation. Clin Cancer Res. 2007; 13(16):4891-9. DOI: 10.1158/1078-0432.CCR-07-0416. View

12.

Zhu W, Ou Y, Li Y, Xiao R, Shu M, Zhou Y . A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol Pharmacol. 2009; 75(4):812-9. DOI: 10.1124/mol.108.052605. View

13.

Eischen C, Lozano G . p53 and MDM2: antagonists or partners in crime?. Cancer Cell. 2009; 15(3):161-2. DOI: 10.1016/j.ccr.2009.02.004. View

14.

Honda R, Tanaka H, Yasuda H . Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1998; 420(1):25-7. DOI: 10.1016/s0014-5793(97)01480-4. View

15.

Teodoro J, Evans S, Green M . Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. J Mol Med (Berl). 2007; 85(11):1175-86. DOI: 10.1007/s00109-007-0221-2. View

16.

Fridman J, Lowe S . Control of apoptosis by p53. Oncogene. 2003; 22(56):9030-40. DOI: 10.1038/sj.onc.1207116. View

17.

Wang D, Sun Y, Ye F, Li W, Kharbuja P, Gao L . Anti-tumor activity of the X-linked inhibitor of apoptosis (XIAP) inhibitor embelin in gastric cancer cells. Mol Cell Biochem. 2013; 386(1-2):143-52. DOI: 10.1007/s11010-013-1853-x. View

18.

Mujumdar N, Mackenzie T, Dudeja V, Chugh R, Antonoff M, Borja-Cacho D . Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways. Gastroenterology. 2010; 139(2):598-608. PMC: 3587769. DOI: 10.1053/j.gastro.2010.04.046. View

19.

Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

20.

Shangary S, Wang S . Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res. 2008; 14(17):5318-24. PMC: 2676446. DOI: 10.1158/1078-0432.CCR-07-5136. View